Key facts
- It has raised $12.7M across 1 recorded rounds; the latest was Seed Round ($366K) in May 2022.
- Notable investors include University of Alberta.
- IllumiSonics has filed 1 Form D with the SEC, most recently Jul 2022 ($366K sold to 2 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for IllumiSonics
Funding rounds
1 roundsAbout IllumiSonics
Developer of a label-free imaging platform designed to enable non-destructive, high-resolution analysis of tissue architecture for clinical and research applications. The company offers patented optical sectioning and digital reconstruction technology, enabling pathologists, researchers, and biopharmaceutical developers to analyze tissue without dyes, stains, or physical damage.
- Sector
- Healthcare
- HQ
- Waterloo, Canada
- Employees
- 7
- Website
- illumisonics.com/
- Ownership
- Privately Held (backing)
IllumiSonics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IllumiSonics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IllumiSonics in its N-PORT filings yet. We sweep new filings monthly.